Does the multi-biomarker disease activity score have diagnostic value in early rheumatoid arthritis and unclassified arthritis?
Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands.
Karen I
KI
Maijer
Crescendo Bioscience, Inc., South San Francisco, California, USA.
Wanying
W
Li
Crescendo Bioscience, Inc., South San Francisco, California, USA.
Eric H
EH
Sasso
Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK.
Daniëlle M
DM
Gerlag
Crescendo Bioscience, Inc., South San Francisco, California, USA.
Nadine A
NA
Defranoux
Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands University of Cambridge, Cambridge, UK Ghent University, Ghent, Belgium GlaxoSmithKline, Stevenage, UK.
Paul P
PP
Tak
D000328:Adult; D001168:Arthritis / Q000097:blood / Q000175:diagnosis; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000175:diagnosis; D015415:Biomarkers / Q000097:blood*; D003937:Diagnosis, Differential; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D015415:Biomarkers
Disease Activity; Early Rheumatoid Arthritis; Rheumatoid Arthritis